Treatment of Primary Sjogren's Syndrome with Low-Dose Natural Human Interferon-alpha Administered by the Oral Mucosal Route: A Phase II Clinical Trial

The purpose of this investigation was to examine the safety and efficacy of four dosages of natural human interferon-alpha (nHuIFN-alpha) delivered over a 12-week period orally in lozenges (150 IU and 450 IU, once [QD] or three times [TID] daily) compared to placebo in subjects with primary Sjögren&...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of interferon & cytokine research 1999-08, Vol.19 (8), p.943-951
Hauptverfasser:	Ship, Jonathan A., Fox, Philip C., Michalek, Joel E., Cummins, Martin J., Richards, Alan B., Group, IFN Protocol Study
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!